glp 1 powerpoint presentation GLP-1 RA and Cardiovascular Outcomes Nutritional priorities to support GLP-1
Description
Semaglutide should not be used during pregnancy and there may be potential risks to an unborn baby from exposure to semaglutide during pregnancy
Mojsov S, Heinrich G, Wilson IB, Ravazzola M, Orci L, and Habener JF
When a synthetic GLP-1 agonist like semaglutide or tirzepatide activates these receptors, the effects ripple through multiple systems simultaneously
Pharmacological GLP-1 RAs replicate these actions, aiding in managing Type 2 diabetes mellitus (T2DM) and promoting weight loss (23)
they want refinement
However, it might be covered by some plans and with prior authorization
